World Orphan Drug Congress USA 2025
22-24 April 2025
Boston Convention & Exhibition Center
Book a meetingSciensus is proud to sponsor the upcoming World Orphan Drug Congress USA 2025.
The World Orphan Drug Congress is a key event for industry leaders, bringing together pharmaceutical companies, regulators, and patient advocacy groups to advance access to rare disease treatments.
Join us and discover your European end-to-end commercialisation partner for your rare and orphan medicines.
Don’t miss our speaking sessions at the World Orphan Drug Congress USA 2025
Breaking into Europe: Partnerships That Propel U.S. Biotechs to Orphan Drug Success
Time: 1:00pm – 2:00pm
Sciensus speakers:
Guest speakers:
Ms. Kathy Senecal
Grant Castor
Tuesday April 22nd
Breaking into Europe: Partnerships That Propel U.S. Biotechs to Orphan Drug Success
Time: 1:00pm – 2:00pm
Sciensus speakers:
Guest speakers:
Ms. Kathy Senecal
Grant Castor
Wednesday April 23rd
Driving Reimbursement Success in Europe with Real-World Evidence – A Case Study
Time: 1:50pm – 2:10pm
Speakers:
Meet our team attending WODC
Meet us at the event
Join us and discover your European end-to-end commercialisation partner for your rare and orphan medicines.
Learn more about our bespoke rare and orphan disease medicine solution
Expanded access program
Our partners benefit from our regulatory, marketing and commercial strategy expertise, ensuring a faster and easier route to market.
Supply chain management
Sciensus makes the typically complex process of rare disease medicine supply and distribution simple
Real-world data
Partner with Sciensus to develop a Digital+ PSP that drives better outcomes for your patients and demonstrates real-world treatment value.
Patient support programs
Through our patient-facing applications, we generate key insights that enable us to drive the right interventions at the right time, further enhancing the effectiveness of our PSPs.
About Sciensus
Sciensus is a leading European life sciences organisation with over 30 years of experience connecting patients with life-changing medications. We’re redefining patient-centric care, connecting patients with life-changing medicines while empowering pharmaceutical companies and healthcare professionals with the insights needed to improve people’s lives.